Skip to main content
MS-DRG 014 · Pre-MDC · Medical

MS-DRG 014: Allogeneic Bone Marrow Transplant

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: IPPS Table 5 (MS-DRG weights): v44 FY2027 (final rule + CN3) (effective October 1, 2026); MS-DRG Definitions Manual: v44 (effective October 1, 2026). Next CMS release: FY2028 final rule (August 2027), effective October 1, 2027; an April 1 interim grouper update when CMS issues one for the IPPS Table 5 (MS-DRG weights); the FY2028 grouper, effective October 1, 2027 for the MS-DRG Definitions Manual.

Key facts for DRG 014

FY2027 relative weight
11.7942
Higher than 99% of all MS-DRGs
Change vs FY2026
-1.9%
FY2026 weight 12.0179
Geometric mean LOS
26.0 days
Arithmetic mean 29.0 days
MDC
Pre-MDC
Pre-MDC (transplants, tracheostomy, ECMO)
Severity level
single severity level
National unadjusted operating payment
$80,766.68
Weight × $6,848.00 FY2027 standardized amount; capital adds $6,368.28
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 014 is a medical group in the Pre-MDC set (transplants, tracheostomy and ECMO), with no CC/MCC severity split. CMS assigns it a FY2027 relative weight of 11.7942 with a geometric mean length of stay of 26.0 days and an arithmetic mean of 29.0. Its weight moved down 1.9% from FY2026 (12.0179). That weight is in the top 1% of all MS-DRGs. The v44 Definitions Manual assigns it through 26 non-operating room procedures codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 014 the FY2027 relative weight is 11.7942 against 12.0179 in FY2026, a fall of 1.86%.

FY2026 versus FY2027 payment factors for MS-DRG 014
MetricFY2026FY2027Change
Relative weight12.017911.7942-0.2237
Geometric mean LOS (days)25.726.0+0.3
Arithmetic mean LOS (days)28.729.0+0.3
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 014 stands alone: CMS does not split this base group by CC or MCC severity, so complication documentation does not move the assignment, although it still affects quality and risk-adjustment reporting.

National unadjusted payment for DRG 014

Multiplying the FY2027 relative weight (11.7942) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. This group has no CC/MCC sibling, so the amount does not change with secondary-diagnosis capture.

FY2027 national unadjusted IPPS payment for MS-DRG 014
ComponentNational rateDRG 014
Operating (labor and nonlabor share)$4,519.68 + $2,328.32 = $6,848.00$80,766.68
Capital (federal rate)$539.95$6,368.28
Operating plus capital$87,134.96
Assumes the full annual update (the hospital submitted quality data and is a meaningful EHR user). A hospital with a reduced update starts from $78,240.25 to $80,135.10 for the operating portion of this DRG.

These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 014.

Grouper logic (v44 Definitions Manual)

Non-Operating Room Procedures: 26 ICD-10-PCS codes in this DRG's assignment logic; the first 12 are shown.

Non-Operating Room Procedures codes in the logic for DRG 014 (sample)
ICD-10-PCS codeDescription
30233G2Transfusion of Allogeneic Related Bone Marrow into Peripheral Vein, Percutaneous Approach
30233G3Transfusion of Allogeneic Unrelated Bone Marrow into Peripheral Vein, Percutaneous Approach
30233G4Transfusion of Allogeneic Unspecified Bone Marrow into Peripheral Vein, Percutaneous Approach
30233U2Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
30233U3Transfusion of Allogeneic Unrelated T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
30233U4Transfusion of Allogeneic Unspecified T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
30233X2Transfusion of Allogeneic Related Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
30233X3Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
30233X4Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
30233Y2Transfusion of Allogeneic Related Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
30233Y3Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
30233Y4Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach

Documentation and denial exposure

As a medical DRG, assignment depends on the principal diagnosis sequenced from the attending's documentation; a secondary condition sequenced first, or a symptom code in place of the confirmed diagnosis, changes the MDC or the DRG. Because this family has no severity split, review risk concentrates on medical-necessity of the admission itself and on the two-midnight benchmark. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

For teams evaluating QuickIntell software

Evaluate a documentation and coding workflow for DRG 014

Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — DRG 014

What is MS-DRG 014?

MS-DRG 014 is "Allogeneic Bone Marrow Transplant", a medical Medicare Severity Diagnosis-Related Group in the Pre-MDC set (transplants, tracheostomy and ECMO). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 014?

The FY2027 relative weight is 11.7942 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 12.0179, a change of -1.9%.

What is the Medicare base payment for MS-DRG 014?

$80,766.68 for operating costs plus $6,368.28 for capital, $87,134.96 together, at the FY2027 national rates: weight 11.7942 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.

What is the average length of stay for DRG 014?

CMS reports a geometric mean length of stay of 26.0 days and an arithmetic mean of 29.0 days for FY2027. The geometric mean is used for transfer-payment calculations.

What documentation supports the severity level of DRG 014?

DRG 014 has no CC or MCC sibling, so secondary-diagnosis capture does not change the group or its 11.7942 weight. Review effort belongs instead on the principal diagnosis sequencing and the 26 procedure codes that place the stay in this group, and on medical necessity of the inpatient admission itself under the two-midnight benchmark against a 26.0-day geometric mean stay, which is where denials for single-severity groups concentrate.

Which codes group to DRG 014?

The v44 Definitions Manual lists 26 non-operating room procedures codes for this group. Examples from the non-operating room procedures list, 30233G2 (Transfusion of Allogeneic Related Bone Marrow into Peripheral Vein, Percutaneous Approach); 30233G3 (Transfusion of Allogeneic Unrelated Bone Marrow into Peripheral Vein, Percutaneous Approach); 30233G4 (Transfusion of Allogeneic Unspecified Bone Marrow into Peripheral Vein, Percutaneous Approach); 30233U2 (Transfusion of Allogeneic Related T-cell Depleted Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach).

Is DRG 014 a post-acute transfer DRG?

No. DRG 014 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.